Q1 2023 Holdings
Filed 2023-05-15 | 44 holdings | $509.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $32.2M | 1,212,096 | 6.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.3M | 818,505 | 5.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $28.9M | 3,740,761 | 5.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $27.2M | 677,426 | 5.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $24.9M | 1,355,151 | 4.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $24.7M | 659,211 | 4.9% |
| Point Biopharma Global Inc | COM | 730541109 | $24.6M | 3,383,029 | 4.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $23.0M | 783,795 | 4.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $22.6M | 1,003,000 | 4.4% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $21.9M | 149,500 | 4.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $18.6M | 2,192,816 | 3.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $17.6M | 500,000 | 3.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $17.5M | 804,333 | 3.4% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $16.9M | 694,009 | 3.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $16.7M | 1,000,000 | 3.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $15.2M | 755,620 | 3.0% |
| Optinose Inc | COM | 68404V100 | $15.2M | 7,894,736 | 3.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $12.6M | 255,367 | 2.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $12.6M | 1,600,545 | 2.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $10.8M | 658,127 | 2.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $9.7M | 620,326 | 1.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $9.6M | 1,191,581 | 1.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $8.8M | 5,817,368 | 1.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.9M | 257,006 | 1.6% |
| Precision Biosciences Inc | COM | 74019P108 | $6.1M | 8,099,799 | 1.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $6.0M | 278,334 | 1.2% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $5.9M | 3,153,206 | 1.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.4M | 507,500 | 0.9% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $4.4M | 1,022,537 | 0.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $4.3M | 1,051,267 | 0.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $4.2M | 380,000 | 0.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.1M | 900,000 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.8M | 70,371 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.8M | 250,000 | 0.7% |
| Aclaris Therapeutics Inc(ACRS)Call | COM | 00461U105 | $2.0M | 250,000 | 0.4% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $1.9M | 347,824 | 0.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $1.9M | 141,526 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.7M | 97,544 | 0.3% |
| Praxis Precision Medicines I | COM | 74006W108 | $1.6M | 2,032,550 | 0.3% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $1.3M | 80,000 | 0.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $997.3K | 210,405 | 0.2% |
| Avalo Therapeutics Inc | COM NEW | 05338F207 | $830.6K | 474,639 | 0.2% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $722.8K | 120,864 | 0.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $362.4K | 39,222 | 0.1% |